• 1. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 2. Evidence of field induced slow magnetic relaxation in cis-[Co(hfac)2(H2O)2] exhibiting tri-axial anisotropy with a negative axial component?
  Denis V. Korchagin,Elena A. Yureva,Alexander V. Akimov,Eugenii Ya. Misochko,Gennady V. Shilov,Artem D. Talantsev,Roman B. Morgunov,Alexander A. Shakin,Sergey M. Aldoshin,Boris S. Tsukerblat Dalton Trans., 2017,46, 7540-7548
• 3. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 4. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 5. Fe/S-Catalyzed synthesis of 2-benzoylbenzoxazoles and 2-quinolylbenzoxazoles via redox condensation of o-nitrophenols with acetophenones and methylquinolines?
  Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Cinnamic acids and derivatives Coumaric acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Cinnamic acids and derivatives Hydroxycinnamic acids and derivatives Coumaric acids and derivatives

Chemical Profile of (2E)-3-(2-ethoxyphenyl)prop-2-enoic acid (CAS No. 59923-03-4)

(2E)-3-(2-ethoxyphenyl)prop-2-enoic acid, identified by its Chemical Abstracts Service (CAS) number 59923-03-4, is a significant compound in the realm of organic chemistry and pharmaceutical research. This compound belongs to the class of α,β-unsaturated carboxylic acids, characterized by its conjugated system of a double bond and a carboxylic acid group. The presence of an ethoxy substituent on the phenyl ring introduces unique electronic and steric properties, making it a valuable scaffold for medicinal chemistry applications.

The molecular structure of (2E)-3-(2-ethoxyphenyl)prop-2-enoic acid consists of a prop-2-enone backbone linked to a phenyl ring at the third carbon position, which is further modified by an ethoxy group. This structural motif contributes to its potential reactivity and biological activity, positioning it as a candidate for further derivatization and exploration in drug discovery programs.

In recent years, there has been growing interest in α,β-unsaturated carboxylic acids due to their versatile biological activities. These compounds often exhibit inhibitory effects on various enzymes and receptors, making them promising candidates for therapeutic intervention. Specifically, derivatives of (2E)-3-(2-ethoxyphenyl)prop-2-enoic acid have been investigated for their potential role in modulating inflammatory pathways and oxidative stress responses.

One of the most compelling areas of research involving (2E)-3-(2-ethoxyphenyl)prop-2-enoic acid is its application in developing novel anti-inflammatory agents. Studies have demonstrated that certain analogs of this compound can inhibit the activity of cyclooxygenase (COX) enzymes, which are key players in the production of prostaglandins involved in inflammation. Additionally, the ethoxyphenyl moiety has been shown to enhance binding affinity to specific protein targets, suggesting its utility in designing more potent and selective inhibitors.

Furthermore, the conjugated double bond system in (2E)-3-(2-ethoxyphenyl)prop-2-enoic acid allows for facile functionalization through various chemical reactions such as Michael additions, aldol condensations, and cross-coupling reactions. These reactions enable the synthesis of a diverse array of derivatives with tailored biological properties. For instance, researchers have explored the use of this compound as a precursor for creating chiral molecules with enhanced pharmacological activity.

The pharmacokinetic profile of (2E)-3-(2-ethoxyphenyl)prop-2-enoic acid is also an area of active investigation. Preliminary studies suggest that this compound exhibits moderate solubility in both aqueous and lipid environments, which could be advantageous for formulating oral or parenteral dosage forms. Additionally, its metabolic stability has been assessed through in vitro studies using liver microsomes, revealing potential pathways for biotransformation and elimination from the body.

In conclusion, (2E)-3-(2-ethoxyphenyl)prop-2-enoic acid (CAS No. 59923-03-4) represents a promising scaffold for pharmaceutical development. Its unique structural features and demonstrated biological activities make it a valuable candidate for further exploration in drug discovery. As research continues to uncover new therapeutic applications, this compound is poised to play a significant role in the development of next-generation therapeutics aimed at addressing various diseases and disorders.

• 2373-79-7(3-(4-ethoxyphenyl)prop-2-enoic acid)
• 6972-61-8(2,4-Dimethoxycinnamic acid)
• 1011-54-7((E)-3-(2-methoxyphenyl)prop-2-enoic acid)
• 14737-91-8(cis-2-Methoxycinnamic acid)
• 69038-81-9(2-Ethoxycinnamic acid)
• 13063-09-7(2,4,6-Trimethoxycinnamic Acid)
• 10538-51-9((E)-3-(2,5-Dimethoxyphenyl)acrylic acid)
• 6099-03-2((E)-3-(2-Methoxyphenyl)acrylic Acid)
• 55620-18-3(2-Acetoxycinnamic acid)
• 16909-09-4(2,4-Dimethoxycinnamic acid)